| Program |
Therapeutic Area |
Development Stage |
Milestones |
| Preclinical |
Phase 1
Phase 2
|
Randomised Studies |
Filing |
Reimbursement |
|
| Ruzurgi |
Neurology |
Available via Named Patient Supply
Pending
|
TGA registration September 2021.
Reimbursement Q2 2022
|
| K-Citra |
Urology |
K-Citra Registered
|
Available since December 2021 |
| ORS003 |
Hospital Critical Care |
Transfer of manufacturer
|
MA transfer estimated February 2022 |
| ORS004 |
Oncology |
In development
|
To be advised |
| ORS005 |
Antimycobacterial |
Final Regulatory preparation for submission
|
Registration estimated 2023 |
